DOI: 10.1111/cea.70468 ISSN: 0954-7894
Benralizumab Inhibits Upper Airway Expression of Thymic Stromal Lymphopoietin in Severe Asthma
Hazel Marriott, Marc Duchesne, Jalal Moolji, Adil Adatia, Subhabrata Moitra, Paige LacySummary
Treatment with benralizumab significantly reduced nasal TSLP in patients with severe asthma. Nasal TSLP shows potential as a pharmacodynamic biomarker, pending validation in larger, randomized studies.